SMARCA4 MUTATIONS PROMOTE CHEMOTHERAPY RESISTANCE IN T-ACUTE LYMPHOBLASTIC LEUKEMIA THROUGH ALTERED CHROMATIN REMODELING AT AP1-ASSOCIATED REGULATORY REGIONS
Violeta Garcia-Hernandez, Maria Maqueda, Giulia Faccincani, Alba Vidal, Jessica Gonzalez, Arnau Iglesias, Marina Alcaide-Miranda, Cinzia Benetti, Eleonora Ponzo, Francesco Boccalatte, Sarah Bray, Lluis Espinosa, Anna Bigas
This study shows SMARCA4 mutations in T-ALL lead to chemotherapy resistance by altering chromatin remodeling at AP-1 regulatory regions, reducing stress response genes.
bioRxiv · Nov 3, 2026 · PreprintCancer Biology